Kentucky Governor Andy Beshear has moved to broaden access to the state’s medical cannabis program, signing an executive order that expands the range of medical conditions eligible for treatment and renewing his call for wider marijuana reform.
Speaking at a news conference last week, Beshear said the action is intended to provide greater clarity around Kentucky’s existing medical cannabis law. According to the governor, the current statute already allows marijuana to be recommended for symptoms such as nausea and chronic pain.
His order makes it clear that patients diagnosed with illnesses commonly associated with those symptoms may also qualify for treatment. The move comes after state lawmakers chose not to advance a proposal that would have formally widened the list of qualifying conditions during the most recent legislative session.
In response, Beshear used executive authority to add 15 specific disorders to the eligibility framework. Among the newly recognized conditions are HIV/AIDS, Parkinson’s disease, sickle cell anemia, glaucoma, arthritis, and fibromyalgia.
Beshear said Kentucky’s Office of Medical Cannabis will revise program guidelines to better reflect what he described as the original intent of the law. He argued that uncertainty surrounding eligibility has prevented some residents from seeking treatment that may already be available to them under existing regulations.
The executive order builds on legislation approved in 2023 that legalized medical cannabis in the state. The program officially began operating early last year and has continued to expand. State officials report that 32 licensed cannabis businesses are currently operating, while roughly 500 healthcare professionals are authorized to recommend the treatment.
Nearly 24,000 residents have enrolled so far. Beshear estimated that the latest changes could make over 400,000 additional Kentuckians eligible for medical cannabis access. He framed the decision as a practical step aimed at improving quality of life rather than engaging in political disputes.
When asked whether the state attorney general might challenge the order, Beshear dismissed those concerns, maintaining that the action does not create new law but instead clarifies how existing provisions should be interpreted. He pointed to sickle cell anemia as an example, noting that patients often experience chronic pain, a symptom already recognized under the program.
The governor also referenced recent research from the University of Kentucky that found an association between regulated medical cannabis dispensaries and reduced opioid overdose rates.
Beyond medical access, Beshear reiterated support for federal efforts to reclassify marijuana, saying such a change would encourage additional scientific research. He also voiced support for broader decriminalization, arguing that people should not face jail time solely for marijuana possession, particularly when many use it to manage legitimate medical conditions.
These progressive decisions taken by Gov. Beshear are likely to be welcomed by the broader cannabis industry, including established entities like Tilray Brands Inc. (NASDAQ: TLRY) (TSX: TLRY) that have long wanted patients to have the right to opt for medical marijuana products that are legally available in case such products can help them manage their symptoms.
About CNW420
CNW420 spotlights the latest developments in the rapidly evolving cannabis industry through the release of an article each business day at 4:20 p.m. Eastern – a tribute to the time synonymous with cannabis culture. The concise, informative content serves as a gateway for investors interested in the legalized cannabis sector and provides updates on how regulatory developments may impact financial markets. If marijuana and the burgeoning industry surrounding it are on your radar, CNW420 is for you! Check back daily to stay up-to-date on the latest milestones in the fast -changing world of cannabis.
To receive SMS alerts from CNW, text CANNABIS to 888-902-4192 (U.S. Mobile Phones Only)
For more information, please visit https://www.CannabisNewsWire.com
Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: https://www.CannabisNewsWire.com/Disclaimer
CannabisNewsWire
Denver, CO
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.com
CannabisNewsWire is powered by IBN
